cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Chimerix Inc
9 own
23 watching
Current Price
$0.96
$-0.03
(-3.03%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
81.31M
52-Week High
52-Week High
1.57000
52-Week Low
52-Week Low
0.88000
Average Volume
Average Volume
0.23M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization81.31M
icon52-Week High1.57000
icon52-Week Low0.88000
iconAverage Volume0.23M
iconDividend Yield--
iconP/E Ratio--
What does the Chimerix Inc do?
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company s approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs include ONC201 a program for treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients; ONC206, an imipridone, Dopamine Receptor D2 (DRD2) antagonist, and caseinolytic protease P (ClpP) agonist that demonstrated enhanced non-competitive DRD2 antagonism relative to ONC201, which is in Phase I clinical trials to treat solid tumors; ONC212, an imipridone agonist of the orphan G protein-coupled receptors (GPCR) tumor suppressor GPR132, as well as ClpP for solid tumors and hematological malignancies, including pancreatic cancer and leukemias; and dociparstat sodium (DSTAT), which inhibits the activities of key proteins implicated in the resistance of acute myeloid leukemia blasts and leukemic stem cells to chemotherapy. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; and SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.
Read More
How much money does Chimerix Inc make?
News & Events about Chimerix Inc.
Globe Newswire
1 year ago
- Continued Execution and Progress Towards Commercial Approval of Dordaviprone (ONC201) with Global Launch of Phase 3 ACTION Study Confirmed Response in Non-H3 K27M Recurrent Glioblastoma Patient During ONC206 Dose Escalation Strong Balance Sheet with $266 Million in Cash at Year-End and No Debt ...
Globe Newswire
1 year ago
DURHAM, N.C., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Chimerix(NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that Mike Sherman, Chief Executive Officer, will present a ...
Business Wire
1 year ago
Rubric Capital Management LP (Rubric), an investment adviser whose managed funds and accounts collectively own approximately 8.5% of the common stock of Chimerix, Inc. (Chimerix or the Company) (NASDAQ: CMRX), today sent a letter to Chimerixs Board of Directors (the Board). In its letter, Rubric...
Globe Newswire
1 year ago
- Initial Procurement of 319,000 Treatment Courses for $115M with Additional Procurements at BARDAs Discretion Over 10 Years - Emergent BioSolutions, Inc. Payment Increases to $238M Upfront and $136.5M in Potential Milestones - DURHAM, N.C., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Chimerix(NASDAQ:CMRX), a...
PR Newswire
1 year ago
Demand for Comprehensive Cleaning Services Grow Post-Pandemic Demand for Comprehensive Cleaning Services Grow Post-Pandemic PR Newswire NEW YORK, Aug. 26, 2022 FinancialBuzz.com News Commentary NEW YORK, Aug. 26, 2022 /PRNewswire/ -- Due to the growing implementation of AI and automation in...
Frequently Asked Questions
Frequently Asked Questions
What is Chimerix Inc share price today?
plus_minus_icon
Can Indians buy Chimerix Inc shares?
plus_minus_icon
How can I buy Chimerix Inc shares from India?
plus_minus_icon
Can Fractional shares of Chimerix Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Chimerix Inc stocks?
plus_minus_icon
What is today’s traded volume of Chimerix Inc?
plus_minus_icon
What is today’s market capitalisation of Chimerix Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Chimerix Inc?
plus_minus_icon
What percentage is Chimerix Inc down from its 52-Week High?
plus_minus_icon
What percentage is Chimerix Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.96
$-0.03
(-3.03%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00